Approval · Notice of Compliance 4620 · 1996
PLASMANATE: Notice of Compliance 4620
Issued March 1, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4620
- Date
- March 1, 1996
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer's name, changes to the labelling and product monograph
- Therapeutic class
- Blood volume supporter
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLASMANATE | 02206064 | — |
Medicinal ingredients
- PLASMA PROTEIN FRACTION (HUMAN) 50 MG per ML